Trials / Completed
CompletedNCT05314855
Brain Clock and Insulin Resistance
Role of the Central Brain Clock in the Pathophysiology of Insulin Resistance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
In this observational cohort study the investigators will determine the activity rhythm of the suprachiasmatic nucleus in humans with progressive stages of insulin resistance, using advanced functional brain imaging (7 Tesla functional MRI).
Detailed description
Type 2 diabetes mellitus (T2DM) has an increasing worldwide incidence. Insulin resistance is a key pathophysiological process in the development of hyperglycemia in patients with T2DM. Disruption of circadian synchrony leads to insulin resistance. Animal studies and post-mortem human brain studies suggest that the master brain clock in the hypothalamic suprachiasmatic nucleus (SCN) plays a role in the development of insulin resistance. Up to now, no-one has investigated whether the in vivo activity rhythm of the SCN is affected in patients with insulin resistance. The investigators hypothesize that the master brain clock has an important role in the development of human insulin resistance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | functional MRI | Subjects will undergo functional MRI at 4 time points in 24 hours. |
Timeline
- Start date
- 2023-01-04
- Primary completion
- 2025-01-18
- Completion
- 2025-11-01
- First posted
- 2022-04-06
- Last updated
- 2026-01-07
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05314855. Inclusion in this directory is not an endorsement.